Chemical Compound

(2R,3R,6R,8R,9R,10S,11S,12R)-2-[(1R,2R)-1,2-dihydroxy-1-methyl-butyl]-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-8-hydroxy-11-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-(propylaminomethyl)tetrahydropyran-2-yl]oxy-3,6,8,10,12-pentamethyl-1-oxa-4-azacyclotridecan-13-one

CAS Registry Number 280755-12-6
返回搜索 申请报价
(2R,3R,6R,8R,9R,10S,11S,12R)-2-[(1R,2R)-1,2-dihydroxy-1-methyl-butyl]-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-8-hydroxy-11-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-(propylaminomethyl)tetrahydropyran-2-yl]oxy-3,6,8,10,12-pentamethyl-1-oxa-4-azacyclotridecan-13-one 结构式
Primary record

(2R,3R,6R,8R,9R,10S,11S,12R)-2-[(1R,2R)-1,2-dihydroxy-1-methyl-butyl]-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-8-hydroxy-11-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-(propylaminomethyl)tetrahydropyran-2-yl]oxy-3,6,8,10,12-pentamethyl-1-oxa-4-azacyclotridecan-13-one

库存
2,624 克
纯度
99.4 %
CAS
280755-12-6

化合物标识与属性

CAS
280755-12-6
PubChem CID
71244897
SMILES
CCCNC[C@@]1([C@@H](O[C@H](C[C@@]1(C)OC)O[C@H]2[C@@H]([C@H]([C@](C[C@H](CN[C@@H]([C@@H](OC(=O)[C@@H]2C)[C@@](C)([C@@H](CC)O)O)C)C)(C)O)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)C)C)O
Canonical SMILES
CCCNC[C@]1(O)[C@H](C)O[C@@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@](C)(O)C[C@@H](C)CN[C@H](C)[C@H]([C@](C)(O)[C@H](O)CC)OC(=O)[C@@H]2C)C[C@@]1(C)OC

名称与同义词

  • Tulathromycin B
  • Tulathromycin B [USAN]
  • T5PDD839DA
  • UNII-T5PDD839DA
  • RefChem:192489
  • Tulathromycin B - 95%
  • TULATHROMYCIN B [MI]
  • 280755-12-6
  • TULATHROMYCIN COMPONENT B
  • Tulathromycin Structural Isomer
  • SCHEMBL14672083
  • CHEBI:182496
  • C41H79N3O12
  • MSK10016-100M
  • ZINC306120615
  • CP-547272
  • AT167464
  • DA-68416
  • FT152643
  • CP 547272
  • CP-547,272
  • C21789
  • Tulathromycin B Solution in Methanol, 100ug/mL
  • A900910
  • (2R,3R,6R,8R,9R,10S,11S,12R)-2-[(2R,3R)-2,3-dihydroxypentan-2-yl]-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-hydroxy-11-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-(propylaminomethyl)oxan-2-yl]oxy-3,6,8,10,12-pentamethyl-1-oxa-4-azacyclotridecan-13-one
  • Q27289703
  • Tulathromycin B - 5% (mixture with Tulathromycin A)
  • Tulathromycin B, approximately 5per cent(As a mixture with Tulathromycin A)
  • Tulathromycin B, approximately 5%(As a mixture with Tulathromycin A)
  • (2R,3R,6R,8R,9R,10S,11S,12R)-11-((2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-((propylamino)methyl)-alpha-L-ribo-hexopyranosyl)oxy)-2-((1R,2R)-1,2-dihydroxy-1-methylbutyl)-8-hydroxy-3,6,8,10,12-pentamethyl-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-4-azacyclotridecan-13-one
  • (2R,3R,6R,8R,9R,10S,11S,12R)-11-((2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-((propylamino)methyl)-alpha-L-ribo-hexopyranosyl)oxy)-2-((1S,2R)-1,2-dihydroxy-1-methylbutyl)- 8-hydroxy-3,6,8,10,12-pentamethyl-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-4-azacyclotridecan-13-one
  • (2R,3R,6R,8R,9R,10S,11S,12R)-11-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-alpha-L-ribo-hexopyranosyl)oxy]-2-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-8-hydroxy-3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-4-azacyclotridecan-13-one
  • (2R,3R,6R,8R,9R,10S,11S,12R)-2-[(1R,2R)-1,2-dihydroxy-1-methyl-butyl]-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-8-hydroxy-11-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-(propylaminomethyl)tetrahydropyran-2-yl]oxy-3,6,8,10,12-pentamethyl-1-oxa-4-azacyclotridecan-13-one
  • 1-Oxa-4-azacyclotridecan-13-one, 11-((2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-((propylamino)methyl)-alpha-l-ribo-hexopyranosyl)oxy)-2-(1,2-dihydroxy-1-methylbutyl)-8-hydroxy-3,6,8,10,12-pentamethyl-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-d-xylo-hexopyranosyl)oxy)-, (2S,3S,6R,8R,9R,10S,11S,12R)-